NAFDAC敦促尼日利亚专利药品商停止因健康风险而出售假药。 NAFDAC urges Nigerian patent medicine dealers to stop selling counterfeit drugs due to health risks.

尼日利亚食品和药物管理机构NAFDAC敦促专利药品商停止销售低于标准药品和假药,强调它们构成严重的健康危险。 NAFDAC, Nigeria's food and drug regulatory agency, has urged patent medicine dealers to cease the sale of substandard and counterfeit drugs, highlighting the serious health risks they pose. 总干事Mojisola Adeeyyee教授强调,需要真正的产品和遵守规章,将公共福利置于利润之上。 Director-General Prof. Mojisola Adeyeye emphasized the need for genuine products and compliance with regulations, prioritizing public welfare over profit. 该机构的宣传运动旨在减少假冒药品,并通过鼓励药物管制方面的利益有关者之间进行合作,加强社区健康。 The agency's campaign aims to reduce counterfeit medicines and enhance community health by encouraging collaboration among stakeholders in drug regulation.